Cargando…

Exenatide Effects on Cardiometabolic Risk and Weight in Adolescents with Morbid Obesity and Type 2 Diabetes Mellitus: Two Case Reports

OBJECTIVE: Glucagon-like peptide-1 (GLP-1) receptor agonists improve glycemic control and cardiometabolic risk factors in adults with type 2 diabetes mellitus, but pediatric data is sparse. RESEARCH DESIGN AND METHODS: This is the first report to describe the effects of GLP-1 receptor agonist Exenat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Censani, Marisa, Chin, Vivian L, Fennoy, Ilene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864000/ https://www.ncbi.nlm.nih.gov/pubmed/27182560

Ejemplares similares

Weight Loss after Bariatric Surgery in Morbidly Obese Adolescents with MC4R mutations
por: Censani, Marisa, et al.
Publicado: (2013)

Vitamin D Deficiency Is Prevalent in Morbidly Obese Adolescents Prior to Bariatric Surgery
por: Censani, Marisa, et al.
Publicado: (2013)

Effects of Exenatide in a Morbidly Obese Patient with Type 2 Diabetes
por: Kishimoto, Miyako, et al.
Publicado: (2014)

Fat cell size and adipokine expression in relation to gender, depot and metabolic risk factors in morbidly obese adolescents
por: Zhang, Yiying, et al.
Publicado: (2013)

Clinical experience with exenatide in obese North Indian patients with type 2 diabetes mellitus
por: Bawa, Tarunika, et al.
Publicado: (2013)

Exenatide Use in the Management of Type 2 Diabetes Mellitus
por: Kyriacou, Angelos, et al.
Publicado: (2010)

Effect of Laparoscopic Adjustable Gastric Banding on Metabolic Syndrome and Its Risk Factors in Morbidly Obese Adolescents
por: Conroy, Rushika, et al.
Publicado: (2011)

Efficacy and safety of exenatide once‐weekly vs exenatide twice‐daily in Asian patients with type 2 diabetes mellitus
por: Ji, Linong, et al.
Publicado: (2013)

Growth Failure and Excessive Weight Gain in a 10 Year Old Male With Obesity: Approach to Diagnosis, Management, and Treatment of Acquired Hypothyroidism
por: Schumaker, Tiffany, et al.
Publicado: (2018)

Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study
por: KÖSEOĞLU, Derya, et al.
Publicado: (2021)

Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
por: Davis, Timothy M. E., et al.
Publicado: (2022)

MON-LB043 Bariatric Surgery and Weight Loss: Effect on Glucose/Insulin Dynamics in Adolescent PCOS
por: Fennoy, Ilene, et al.
Publicado: (2019)

Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide
por: Voukali, Maria, et al.
Publicado: (2014)

Determining Predictors of Early Response to Exenatide in Patients with Type 2 Diabetes Mellitus
por: Khan, Muhammad, et al.
Publicado: (2015)

Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2015)

Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes
por: Rosenstock, Julio, et al.
Publicado: (2010)

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
por: Seewoodhary, Jason, et al.
Publicado: (2010)

Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2019)

Pediatric Obesity Algorithm: A Practical Approach to Obesity Diagnosis and Management
por: Cuda, Suzanne E., et al.
Publicado: (2019)

Cardiometabolic Morbidity and Mortality with Smoking Cessation, Review of Recommendations for People with Diabetes and Obesity
por: Kos, Katarina
Publicado: (2020)

Two cases of type 2 diabetes mellitus in elderly patients successfully treated with monthly exenatide long‐acting release
por: Takenaka, Kenchi, et al.
Publicado: (2019)

Once-Weekly Exenatide Enhances Weight Loss Maintenance in Adolescents with Severe Obesity: A Randomized, Placebo-Controlled Trial
por: Fox, Claudia K, et al.
Publicado: (2021)

Short-Term Exenatide Treatment Leads to Significant Weight Loss in a Subset of Obese Women Without Diabetes
por: Dushay, Jody, et al.
Publicado: (2012)

ODP396 The Relationship Between Baseline Metabolic Factors and Post-surgical Weight Loss Outcomes in Adolescents Undergoing Laparoscopic Sleeve Gastrectomy
por: Burghard, Anne Claire, et al.
Publicado: (2022)

Safety of exenatide once weekly for 52 weeks in Japanese patients with type 2 diabetes mellitus
por: Onishi, Yukiko, et al.
Publicado: (2012)

Assessment, differential diagnosis, and initial clinical evaluation of the pediatric patient with obesity: An Obesity Medical Association (OMA) Clinical Practice Statement 2022
por: Cuda, Suzanne E., et al.
Publicado: (2022)

Exenatide's effect in reducing weight and glycosylated hemoglobin level in an Arab population with type 2 diabetes
por: Bashier, Alaaeldin M., et al.
Publicado: (2014)

Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus
por: Pereira, Marie, et al.
Publicado: (2017)

Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes mellitus
por: Guclu, Metin, et al.
Publicado: (2017)

Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus
por: Song, Jinfang, et al.
Publicado: (2022)

Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity
por: Gupta, Jyotsna, et al.
Publicado: (2022)

Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes
por: Liu, Jia, et al.
Publicado: (2017)

Setmelanotide: a promising advancement for pediatric patients with rare forms of genetic obesity
por: Trapp, Christine M., et al.
Publicado: (2023)

Formative Development of a Weight Management Intervention for Adolescents with Type 1 Diabetes Mellitus and Obesity
por: Warnick, Jennifer, et al.
Publicado: (2023)

Two-Layer Sustained-Release Microneedles Encapsulating Exenatide for Type 2 Diabetes Treatment
por: Liu, Han, et al.
Publicado: (2022)

Once-Weekly Exenatide in Youth With Type 2 Diabetes
por: Tamborlane, William V., et al.
Publicado: (2022)

Evolution of Exenatide as a Diabetes Therapeutic
por: Bhavsar, Sunil, et al.
Publicado: (2013)

Exenatide once weekly: sustained improvement in glycemic control and cardiometabolic measures through 3 years
por: MacConell, Leigh, et al.
Publicado: (2013)

Association of overweight and obesity with health status, weight management, and exercise behaviors among individuals with type 2 diabetes mellitus or with cardiometabolic risk factors
por: Gavin, James R, et al.
Publicado: (2009)

Clinical Experience of Weight Loss Surgery in Morbidly Obese Korean Adolescents
por: Park, Ji Yeon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_scnu1q9fqjrre6h0iqh19tsd2l